Smart inhalers: Transforming asthma management and the pharmacist's involvement in patient education
Keywords:
Smart inhalers, asthma management, digital health technology, patient education, pharmacists, medication adherenceAbstract
Background: Asthma remains a global healthcare challenge despite advancements in classification, diagnosis, and inhalation therapy. A significant proportion of patients continue to experience uncontrolled asthma, which is linked to factors such as non-adherence to treatment and improper inhaler technique. Aim: This article aims to explore the potential of smart inhalers in transforming asthma management and to highlight the critical role of pharmacists in patient education. Methods: A comprehensive review of literature was conducted, focusing on the prevalence of uncontrolled asthma, the impact of non-adherence, and the integration of digital health technologies, particularly smart inhalers. The study involved an examination of the role of pharmacists in providing asthma education and promoting proper inhaler technique. Results: Findings reveal that 30% to 70% of asthma patients are non-adherent to their medication regimens. Smart inhalers equipped with digital health technologies can enhance medication adherence by providing real-time feedback to patients regarding their inhaler use and asthma status. The involvement of pharmacists in patient education is crucial for optimizing inhaler technique and improving overall asthma management. Conclusion: Smart inhalers represent a promising advancement in asthma care by addressing non-adherence and enhancing self-management.
Downloads
References
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204–1222.
Ismaila AS, Sayani AP, Marin M, et al. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med 2013; 13: 70. DOI: https://doi.org/10.1186/1471-2466-13-70
Pavord ID, Mathieson N, Scowcroft A, et al. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis. NPJ Prim Care Respir Med 2017; 27: 17. DOI: https://doi.org/10.1038/s41533-017-0014-1
Racine G, Forget A, Moullec G, et al. Predictors of asthma control and exacerbations: a real-world study. J Allergy Clin Immunol Pract 2021; 9: 2802–2811.e2. DOI: https://doi.org/10.1016/j.jaip.2021.04.049
Haselkorn T, Fish JE, Zeiger RS, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2009; 124: 895–902.e1-4. DOI: https://doi.org/10.1016/j.jaci.2009.07.035
Sundbom F, Malinovschi A, Lindberg E, et al. Effects of poor asthma control, insomnia, anxiety and depression on quality of life in young asthmatics. J Asthma 2016; 53: 398–403. DOI: https://doi.org/10.3109/02770903.2015.1126846
Sadatsafavi M, McTaggart-Cowan H, Chen W, et al. Quality of life and asthma symptom control: room for improvement in care and measurement. Value Health 2015; 18: 1043–1049. DOI: https://doi.org/10.1016/j.jval.2015.07.008
Sadatsafavi M, Chen W, Tavakoli H, et al. Saving in medical costs by achieving guideline-based asthma symptom control: a population-based study. Allergy 2016; 71: 371–377. DOI: https://doi.org/10.1111/all.12803
Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med 2014; 24: 14009. DOI: https://doi.org/10.1038/npjpcrm.2014.9
FitzGerald JM, Boulet LP, McIvor RA, et al. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J 2006; 13: 253–259. DOI: https://doi.org/10.1155/2006/753083
Centers for Disease Control and Prevention. AsthmaStats: uncontrolled asthma among adults, https://www.cdc.gov/asthma/asthma_stats/uncontrolled-asthma-adults-2019.htm
Murray S, Labbé S, Kaplan A, et al. A multi-stakeholder perspective on asthma care in Canada: findings from a mixed methods needs assessment in the treatment and management of asthma in adults. Allergy Asthma Clin Immunol 2018; 14: 36. DOI: https://doi.org/10.1186/s13223-018-0261-x
Global Initiative for Asthma. Global strategy for asthma management and prevention, http://www.ginasthma.org (2022)
Yang CL, Hicks EA, Mitchell P, et al. Canadian Thoracic Society 2021 Guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can J Respir Crit Care Sleep Med 2021; 5: 348–361. DOI: https://doi.org/10.1080/24745332.2021.1945887
Tomisa G, Horváth A, Tamási L. Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study. J Asthma Allergy 2019; 12: 297–307. DOI: https://doi.org/10.2147/JAA.S211246
Kuti BP, Omole KO, Kuti DK. Factors associated with childhood asthma control in a resource-poor center. J Family Med Prim Care 2017; 6: 222–230. DOI: https://doi.org/10.4103/jfmpc.jfmpc_271_16
Aschalew A, Kebed RA, Demie TG, et al. Assessment of level of asthma control and related factors in children attending pediatric respiratory clinics in Addis Ababa, Ethiopia. BMC Pulm Med 2022; 22: 70. DOI: https://doi.org/10.1186/s12890-022-01865-8
McGhan SL, MacDonald C, Befus AD. Factors associated with poor asthma control in children aged five to 13 years. Can Respir J 2006; 13: 23–29. DOI: https://doi.org/10.1155/2006/149863
Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102: 593–604. DOI: https://doi.org/10.1016/j.rmed.2007.11.003
Ovchinikova L, Smith L, Bosnic-Anticevich S. Inhaler technique maintenance: gaining an understanding from the patient’s perspective. J Asthma 2011; 48: 616–624. DOI: https://doi.org/10.3109/02770903.2011.580032
Gosavi S, Nadig P, Haran A. Factors contributing towards poor asthma control in patients on regular medication. J Clin Diagn Res 2016; 10: OC31–OC35. DOI: https://doi.org/10.7860/JCDR/2016/18670.8052
Tomisa G, Horváth A, Sánta B, et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 2021; 17: 95. DOI: https://doi.org/10.1186/s13223-021-00598-3
Abrahamsen R, Gundersen GF, Svendsen MV, et al. Possible risk factors for poor asthma control assessed in a cross-sectional population-based study from Telemark, Norway. PLoS ONE 2020; 15: e0232621. DOI: https://doi.org/10.1371/journal.pone.0232621
Bloomberg GR, Banister C, Sterkel R, et al. Socioeconomic, family, and pediatric practice factors that affect level of asthma control. Pediatrics 2009; 123: 829–835. DOI: https://doi.org/10.1542/peds.2008-0504
Laba TL, Jan S, Zwar NA, et al. Cost-related underuse of medicines for asthma-opportunities for improving adherence. J Allergy Clin Immunol Pract 2019; 7: 2298–2306.e12. DOI: https://doi.org/10.1016/j.jaip.2019.03.024
Håkansson KEJ, Backer V, Ulrik CS. Socioeconomic biases in asthma control and specialist referral of possible severe asthma. Eur Respir J 2021; 58: 2100741. DOI: https://doi.org/10.1183/13993003.00741-2021
de Marco R, Cazzoletti L, Cerveri I, et al; ISAYA Study Group. Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma. Int Arch Allergy Immunol 2005; 138: 225–234. DOI: https://doi.org/10.1159/000088723
Akinbami LJ, Salo PM, Cloutier MM, et al. Primary care clinician adherence with asthma guidelines: the National Asthma Survey of Physicians. J Asthma 2020; 57: 543–555. DOI: https://doi.org/10.1080/02770903.2019.1579831
Braido F, Baiardini I, Alleri P, et al. Asthma management in a specialist setting: results of an Italian respiratory society survey. Pulm Pharmacol Ther 2017; 44: 83–87. DOI: https://doi.org/10.1016/j.pupt.2017.03.013
Halterman JS, Yoos HL, Kaczorowski JM, et al. Providers underestimate symptom severity among urban children with asthma. Arch Pediatr Adolesc Med 2002; 156: 141–146. DOI: https://doi.org/10.1001/archpedi.156.2.141
Asthma and Allergy Foundation of America. Asthma: Weather, https://www.aafa.org/weather-triggers-asthma
Berko JK, Brown S, Elward KS, et al. 2020 Focused Updates to the Asthma Management Guidelines. NIH Publication No. 20-HL-8140, 2020.
Lindsay JT, Heaney LG. Nonadherence in difficult asthma – facts, myths, and a time to act. Patient Pref Adher 2013; 7: 329–336. DOI: https://doi.org/10.2147/PPA.S38208
Partridge MR, van der Molen T, Myrseth S-E, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13. DOI: https://doi.org/10.1186/1471-2466-6-13
Bårnes CB, Ulrik CS. Asthma adherence to inhaled corticosteroids: current status and future perspectives. Respir Care 2015; 60: 455–468. DOI: https://doi.org/10.4187/respcare.03200
Dima AL, van Ganse E, Stadler G, et al. Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study. Eur Respir J 2019; 54: 1900901. DOI: https://doi.org/10.1183/13993003.00901-2019
NICE Clinical Guideline 76. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence, https://www.nice.org.uk/guidance/cg76
Sanchis J, Gich I, Pedersen S; Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time? Chest 2016; 150: 394–406. DOI: https://doi.org/10.1016/j.chest.2016.03.041
Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL Study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract 2017; 5: 1071–1081. DOI: https://doi.org/10.1016/j.jaip.2017.01.004
Lussier M-T, Richard C. The motivational interview. Can Fam Physician 2007; 53: 2117–2118.
Miller WR, Moyers TB. Motivational interviewing and the clinical science of Carl Rogers. J Consult Clin Psychol 2017; 85: 757–766. DOI: https://doi.org/10.1037/ccp0000179
Elwyn G, Dehlendorf C, Epstein RM, et al. Shared decision making and motivational interviewing: achieving patient-centered care across the spectrum of health care problems. Ann Fam Med 2014; 12: 270–275. DOI: https://doi.org/10.1370/afm.1615
Motivational Interviewing Network of Trainers. Understanding motivational interviewing, https://motivationalinterviewing.org/understanding-motivational-interviewing
Swami V, Cho J-G, Smith T, et al. Confidence of nurses with inhaler device education and competency of device use in a specialised respiratory inpatient unit. Chron Respir Dis 2021; 18: 14799731211002241. DOI: https://doi.org/10.1177/14799731211002241
Prasad S, Moore M, Sathyamurthy R. Confidence and aptitude of healthcare professionals at demonstrating inhaler technique. Thorax 2018; 73(Suppl. 4): A204. DOI: https://doi.org/10.1136/thorax-2018-212555.348
Gregory K. Important role of asthma educators. Paper presented at 5 Things to Know: the Important Role of the Asthma Educator. Allergy & Asthma Network, https://allergyasthmanetwork.org/?s=asthma+educator&id=1769409
Asthma Initiative of Michigan. Asthma educators, https://getasthmahelp.org/asthma-educator.aspx
Health Canada. eHealth, https://www.canada.ca/en/health-canada/services/health-care-system/ehealth.html#shr-pg0
Cummins N, Schuller BW. Five crucial challenges in digital health. Front Digit Health 2020; 2: 536203. DOI: https://doi.org/10.3389/fdgth.2020.536203
Kuwabara A, Su S, Krauss J. Utilizing digital health technologies for patient education in lifestyle medicine. Am J Lifestyle Med 2020; 14: 137–142. DOI: https://doi.org/10.1177/1559827619892547
Mosnaim G, Safioti G, Brown R, et al. Digital health technology in asthma: a comprehensive scoping review. J Allergy Clin Immunol Pract 2021; 9: 2377–2398. DOI: https://doi.org/10.1016/j.jaip.2021.02.028
Smart Patient. What are digital therapeutics? Definitions and terminology explained, https://www.smartpatient.eu/blog/what-are-digital-therapeutics-dtx-definition-and-terminology
Golata P. Wearable healthcare: digital therapeutics and the future of medical technology, https://www.tti.com/content/ttiinc/en/resources/marketeye/categories/new-technology/me-golata-20220210.html
Datareportal. Digital around the world, https://datareportal.com/global-digital-overview
Statista. Smartphone users in Canada 2018–2024, https://www.statista.com/statistics/467190/forecast-of-smartphone-users-in-canada
Statistics Canada. Canada’s population estimates: age and sex, July 1, 2019, https://www150.statcan.gc.ca/n1/daily-quotidien/190930/dq190930a-eng.htm
IQVIA Institute. Digital health trends 2021, https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/digital-health-trends-2021/iqvia-institute-digital-health-trends-2021.pdf?_=1642643073822
IEEE Standards Association. Mobile health applications. Version 1.0, https://standards.ieee.org/content/dam/ieee-standards/standards/web/governance/iccom/IC21-003-Mobile_Health_Applications.pdf
Research 2 Guidance. 325,000 mobile health apps available in 2017 – Android now the leading mHealth platform, https://research2guidance.com/325000-mobile-health-apps-available-in-2017
NEN. Health and wellness apps: new international guidelines to help to sort the best from the rest, https://www.nen.nl/en/health-and-welness-apps
Makri A. Bridging the digital divide in health care. Lancet Digital Health 2019; 1: e204–e205. DOI: https://doi.org/10.1016/S2589-7500(19)30111-6
Taylor K, Silver L; Pew Research Center. Smartphone ownership is growing rapidly around the world, but not always equally, https://www.pewresearch.org/global/2019/02/05/smartphone-ownership-is-growing-rapidly-around-the-world-but-not-always-equally
Neter E, Brainin E. eHealth literacy: extending the digital divide to the realm of health information. J Med Internet Res 2012; 14: e19. DOI: https://doi.org/10.2196/jmir.1619
International Telecommunication Union. Measuring digital development: facts and figures, https://www.itu.int/en/ITU-D/Statistics/Documents/facts/FactsFigures2021.pdf
Lee MK, Rich K. Who is included in human perceptions of AI?: Trust and perceived fairness around healthcare AI and cultural mistrust. In: CHI conference on human factors in computing systems (CHI ’21). Yokohama, Japan, May 8–13 2021, p. 14. New York, NY, USA: ACM. DOI: https://doi.org/10.1145/3411764.3445570
Canadian Race Relations Foundation. Race relations in Canada 2021: a survey of Canadian public opinion and experience, https://crrf-fcrr.ca/2021/11/race-relations-in-canada-2021-a-survey-of-canadian-public-opinion-and-experience/
Anderson A, Arthur A, Billioux A, et al. The path to techquity: an introduction to key issues impacting equitable design & deployment of technology in the US healthcare system, https://www.ipsos.com/sites/default/files/2022_03_07_Ipsos_HLTH_Techquity_Whitepaper.pdf
Sharon T. The Googlization of health research: from disruptive innovation to disruptive ethics. Pers Med 2016; 13: 563–574. DOI: https://doi.org/10.2217/pme-2016-0057
Schmietow B, Marckmann G. Mobile health ethics and the expanding role of autonomy. Med Health Care Philos 2019; 22: 623–630. DOI: https://doi.org/10.1007/s11019-019-09900-y
Brall C, Schröder-Bäck P, Maeckelberghe E. Ethical aspects of digital health from a justice point of view. Eur J Public Health 2019; 29(Suppl. 3): 18–22. DOI: https://doi.org/10.1093/eurpub/ckz167
Cirillo D, Catuara-Solarz S, Morey C, et al. Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare. NPI Digit Med 2020; 3: 81. DOI: https://doi.org/10.1038/s41746-020-0288-5
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
